{"id":2257,"date":"2026-08-12T10:23:25","date_gmt":"2026-08-12T15:23:25","guid":{"rendered":"https:\/\/global-pharma.com.co\/?p=2257"},"modified":"2026-08-13T09:56:09","modified_gmt":"2026-08-13T14:56:09","slug":"rebecsinib-ensayo-clinico-cancer-de-sangre","status":"publish","type":"post","link":"https:\/\/global-pharma.com.co\/en\/rebecsinib-ensayo-clinico-cancer-de-sangre\/","title":{"rendered":"Nuevo ensayo cl\u00ednico ofrece esperanza para pacientes con c\u00e1ncer de sangre"},"content":{"rendered":"<p class=\"wp-block-paragraph\">A pesar de los avances en medicina, ciertos tipos de c\u00e1ncer de la sangre \u2014como la leucemia mieloide aguda y la mielofibrosis de alto riesgo\u2014 siguen siendo dif\u00edciles de tratar. Muchas veces, aunque los tratamientos iniciales funcionan por un tiempo, la enfermedad regresa. La raz\u00f3n principal de esta reca\u00edda se encuentra en las <strong>c\u00e9lulas madre cancerosas<\/strong>, unas c\u00e9lulas resistentes que logran &#8220;esconderse&#8221; y volver a hacer crecer el tumor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Para cambiar esta realidad nace <strong>Rebecsinib<\/strong>, una peque\u00f1a mol\u00e9cula en desarrollo que act\u00faa como un freno directo para estas c\u00e9lulas rebeldes.<br><br>\u00bfC\u00f3mo funciona Rebecsinib?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Para sobrevivir y multiplicar el c\u00e1ncer, las c\u00e9lulas madre malignas activan una prote\u00edna llamada <strong>ADAR1<\/strong>. Esta prote\u00edna les sirve como un &#8220;escudo&#8221; para evitar ser destruidas por el sistema inmunitario y para volverse resistentes a los medicamentos tradicionales.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Rebecsinib es el primer f\u00e1rmaco de su clase dise\u00f1ado para <strong>bloquear la acci\u00f3n de ADAR1<\/strong>. Al desactivar este mecanismo, el medicamento:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Elimina la ra\u00edz del problema:<\/strong> Ataca y destruye directamente a las c\u00e9lulas madre cancerosas que causan la reaparici\u00f3n de la enfermedad.<\/li>\n\n\n\n<li><strong>Previene las reca\u00eddas:<\/strong> Evita que el tumor vuelva a crecer con el tiempo.<\/li>\n\n\n\n<li><strong>Aumenta la efectividad:<\/strong> Devuelve al organismo la capacidad de reconocer y combatir a las c\u00e9lulas enfermas.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">\u00bfA qui\u00e9nes beneficiar\u00e1 este avance?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">El objetivo principal de este desarrollo son los pacientes adultos con <strong>leucemia mieloide aguda secundaria<\/strong> o <strong>mielofibrosis<\/strong> que no han tenido \u00e9xito con otros tratamientos o que sufren reca\u00eddas. Actualmente, la tasa de supervivencia a 5 a\u00f1os en estos casos es de apenas un 25 %, por lo que contar con un tratamiento como Rebecsinib responde a una necesidad m\u00e9dica urgente.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Adem\u00e1s, como la prote\u00edna ADAR1 tambi\u00e9n se activa en otros tipos de c\u00e1ncer, este f\u00e1rmaco abre la puerta a futuras terapias para combatir tumores s\u00f3lidos en el futuro.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u00bfEn qu\u00e9 etapa se encuentra la investigaci\u00f3n?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">El proyecto ha avanzado con \u00e9xito en sus pruebas de laboratorio y de fabricaci\u00f3n a escala farmac\u00e9utica. Actualmente se prepara para completar la fase de seguridad e iniciar los <strong>ensayos cl\u00ednicos de Fase 1 en humanos<\/strong>, marcando un paso firme hacia un tratamiento m\u00e1s inteligente y eficaz en oncolog\u00eda.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fuente: https:\/\/www.cirm.ca.gov\/es\/our-progress\/awards\/cancer-stem-cell-interception-rebecsinib-first-class-adar1-inhibitor\/<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>A pesar de los avances en medicina, ciertos tipos de c\u00e1ncer de la sangre \u2014como la leucemia mieloide aguda y la mielofibrosis de alto riesgo\u2014 siguen siendo dif\u00edciles de tratar. Muchas veces, aunque los tratamientos iniciales funcionan por un tiempo, la enfermedad regresa. La raz\u00f3n principal de esta reca\u00edda se encuentra en las c\u00e9lulas madre [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2258,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[6],"tags":[],"class_list":["post-2257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rebecsinib: nuevo ensayo cl\u00ednico para tratar el c\u00e1ncer de sangre<\/title>\n<meta name=\"description\" content=\"Un nuevo ensayo cl\u00ednico eval\u00faa Rebecsinib como tratamiento para ciertos c\u00e1nceres de sangre y abre nuevas posibilidades terap\u00e9uticas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/global-pharma.com.co\/en\/rebecsinib-ensayo-clinico-cancer-de-sangre\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rebecsinib: nuevo ensayo cl\u00ednico para tratar el c\u00e1ncer de sangre\" \/>\n<meta property=\"og:description\" content=\"Un nuevo ensayo cl\u00ednico eval\u00faa Rebecsinib como tratamiento para ciertos c\u00e1nceres de sangre y abre nuevas posibilidades terap\u00e9uticas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/global-pharma.com.co\/en\/rebecsinib-ensayo-clinico-cancer-de-sangre\/\" \/>\n<meta property=\"og:site_name\" content=\"Global Pharma &amp; Logistic S.A.S.\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-12T15:23:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T14:56:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/08\/BLOG-2026-4-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mar\u00eda Camila Sanchez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mar\u00eda Camila Sanchez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/\"},\"author\":{\"name\":\"Mar\u00eda Camila Sanchez\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\"},\"headline\":\"Nuevo ensayo cl\u00ednico ofrece esperanza para pacientes con c\u00e1ncer de sangre\",\"datePublished\":\"2026-08-12T15:23:25+00:00\",\"dateModified\":\"2026-08-13T14:56:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/\"},\"wordCount\":411,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/BLOG-2026-4-1.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/\",\"name\":\"Rebecsinib: nuevo ensayo cl\u00ednico para tratar el c\u00e1ncer de sangre\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/BLOG-2026-4-1.png\",\"datePublished\":\"2026-08-12T15:23:25+00:00\",\"dateModified\":\"2026-08-13T14:56:09+00:00\",\"description\":\"Un nuevo ensayo cl\u00ednico eval\u00faa Rebecsinib como tratamiento para ciertos c\u00e1nceres de sangre y abre nuevas posibilidades terap\u00e9uticas.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#primaryimage\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/BLOG-2026-4-1.png\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/BLOG-2026-4-1.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/rebecsinib-ensayo-clinico-cancer-de-sangre\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/global-pharma.com.co\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuevo ensayo cl\u00ednico ofrece esperanza para pacientes con c\u00e1ncer de sangre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"name\":\"Distribuidor de materias primas farmac\u00e9uticas en Colombia.\",\"description\":\"Principios Activos y Materias Primas en Colombia\",\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/global-pharma.com.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\",\"name\":\"Global Pharma & Logistic S.A.S.\",\"alternateName\":\"Global Pharma & Logistic S.A.S.\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"width\":2133,\"height\":2133,\"caption\":\"Global Pharma & Logistic S.A.S.\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/51710617\\\/admin\\\/dashboard\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\",\"name\":\"Mar\u00eda Camila Sanchez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"caption\":\"Mar\u00eda Camila Sanchez\"},\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/en\\\/author\\\/maria-sanchez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rebecsinib: nuevo ensayo cl\u00ednico para tratar el c\u00e1ncer de sangre","description":"Un nuevo ensayo cl\u00ednico eval\u00faa Rebecsinib como tratamiento para ciertos c\u00e1nceres de sangre y abre nuevas posibilidades terap\u00e9uticas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/global-pharma.com.co\/en\/rebecsinib-ensayo-clinico-cancer-de-sangre\/","og_locale":"en_US","og_type":"article","og_title":"Rebecsinib: nuevo ensayo cl\u00ednico para tratar el c\u00e1ncer de sangre","og_description":"Un nuevo ensayo cl\u00ednico eval\u00faa Rebecsinib como tratamiento para ciertos c\u00e1nceres de sangre y abre nuevas posibilidades terap\u00e9uticas.","og_url":"https:\/\/global-pharma.com.co\/en\/rebecsinib-ensayo-clinico-cancer-de-sangre\/","og_site_name":"Global Pharma &amp; Logistic S.A.S.","article_published_time":"2026-08-12T15:23:25+00:00","article_modified_time":"2026-08-13T14:56:09+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/08\/BLOG-2026-4-1.png","type":"image\/png"}],"author":"Mar\u00eda Camila Sanchez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mar\u00eda Camila Sanchez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#article","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/"},"author":{"name":"Mar\u00eda Camila Sanchez","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c"},"headline":"Nuevo ensayo cl\u00ednico ofrece esperanza para pacientes con c\u00e1ncer de sangre","datePublished":"2026-08-12T15:23:25+00:00","dateModified":"2026-08-13T14:56:09+00:00","mainEntityOfPage":{"@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/"},"wordCount":411,"commentCount":0,"publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"image":{"@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/08\/BLOG-2026-4-1.png","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/","url":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/","name":"Rebecsinib: nuevo ensayo cl\u00ednico para tratar el c\u00e1ncer de sangre","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#primaryimage"},"image":{"@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/08\/BLOG-2026-4-1.png","datePublished":"2026-08-12T15:23:25+00:00","dateModified":"2026-08-13T14:56:09+00:00","description":"Un nuevo ensayo cl\u00ednico eval\u00faa Rebecsinib como tratamiento para ciertos c\u00e1nceres de sangre y abre nuevas posibilidades terap\u00e9uticas.","breadcrumb":{"@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#primaryimage","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/08\/BLOG-2026-4-1.png","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/08\/BLOG-2026-4-1.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/global-pharma.com.co\/rebecsinib-ensayo-clinico-cancer-de-sangre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/global-pharma.com.co\/"},{"@type":"ListItem","position":2,"name":"Nuevo ensayo cl\u00ednico ofrece esperanza para pacientes con c\u00e1ncer de sangre"}]},{"@type":"WebSite","@id":"https:\/\/global-pharma.com.co\/#website","url":"https:\/\/global-pharma.com.co\/","name":"Distribuidor de materias primas farmac\u00e9uticas en Colombia.","description":"Principios Activos y Materias Primas en Colombia","publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/global-pharma.com.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/global-pharma.com.co\/#organization","name":"Global Pharma & Logistic S.A.S.","alternateName":"Global Pharma & Logistic S.A.S.","url":"https:\/\/global-pharma.com.co\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","width":2133,"height":2133,"caption":"Global Pharma & Logistic S.A.S."},"image":{"@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/51710617\/admin\/dashboard\/"]},{"@type":"Person","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c","name":"Mar\u00eda Camila Sanchez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","caption":"Mar\u00eda Camila Sanchez"},"url":"https:\/\/global-pharma.com.co\/en\/author\/maria-sanchez\/"}]}},"_links":{"self":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/2257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/comments?post=2257"}],"version-history":[{"count":2,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/2257\/revisions"}],"predecessor-version":[{"id":2262,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/2257\/revisions\/2262"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/media\/2258"}],"wp:attachment":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/media?parent=2257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/categories?post=2257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/tags?post=2257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}